DSGN FY 2021 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DSGNDesign Therapeutics, Inc.

$569M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$36M

Net Income

-$36M

EPS (Diluted)

$-0.77

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$31M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$391M

Total Liabilities

$8M

Stockholders' Equity

$382M

Cash & Equivalents

$299M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$5,000	+100.0%
Operating Income	-$36M	-$9M	-318.8%
Net Income	-$36M	-$8M	-329.1%